Results 251 to 260 of about 9,888,187 (295)
Some of the next articles are maybe not open access.

Moderate Exercise Improves Depression Parameters in Treatment-Resistant Patients With Major Depressive Disorder

Journal of Psychiatric Research, 2011
Treatment-resistant major depressive disorder (MDD) is a complex condition, with very low remission rates. Physical exercise has been used, with some encouraging results, as an alternative therapy in other depressive disorders. This study assessed the impact on depression and functioning parameters of a moderate intensity exercise program, as an ...
José C. Ribeiro   +2 more
exaly   +4 more sources

Brexpiprazole for treatment-resistant major depressive disorder

Expert Opinion on Pharmacotherapy, 2019
Introduction:Treatment-resistant depression (TRD), seldom interchangeably referred to as 'depression inadequately responding to the standard antidepressant drug,' carries a significant burden. The atypical antipsychotics represent a popular augmentation strategy for antidepressant-resistant depression, although their efficacy/safety profiles vary ...
Fornaro M.   +4 more
openaire   +3 more sources

Axis III disorders in treatment-resistant major depressive disorder

Psychiatry Research, 2003
A number of naturalistic studies have found that medical co-morbidity conveys a worse long-term prognosis in the treatment of major depressive disorder (MDD). The purpose of this study was to test whether the presence of co-morbid medical conditions can predict clinical response in patients with treatment-resistant MDD (TRD) treated with open-label ...
George I, Papakostas   +7 more
openaire   +2 more sources

The bipolar diathesis of treatment-resistant major depressive disorder

International Journal of Psychiatry in Clinical Practice, 2008
Objective. In this study, we determined the prevalence of bipolarity in patients with treatment-resistant depression (TRD) by investigating demographic and clinical characteristics, diagnostic subtypes and illness outcome of patients with resistant depression. Methods.
Young Sup, Woo   +4 more
openaire   +2 more sources

Intravenous Ketamine for Treatment-Resistant Major Depressive Disorder

Annals of Pharmacotherapy, 2012
OBJECTIVE: To evaluate the literature regarding the efficacy and safety of intravenous ketamine for treatment-resistant major depressive disorder (MDD). DATA SOURCES: A MEDLINE search (1966-September 2011) was performed using the terms
Jordan R, Covvey   +2 more
openaire   +2 more sources

Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder

Expert Opinion on Pharmacotherapy, 2018
Pharmacotherapy for the treatment of depressive disorders in Alzheimer's Disease (AD) represents a clinical challenge. pharmacological options are often attempted after a period of watchful waiting (8-12 weeks). monoaminergic antidepressant drugs have shown only modest or null clinical benefits, maybe because the etiology of depressive symptoms in ad ...
Madia Lozupone   +14 more
openaire   +3 more sources

Pramipexole augmentation in treatment-resistant major depressive disorder

Expert Review of Neurotherapeutics, 2013
Evaluation of: Cusin C, Iovieno N, Iosifescu DV et al. A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder. J. Clin. Psychiatry 74(7), e636-e641 (2013). To overcome limited efficacy in antidepressants, clinicians may choose augmentation, switching to a different ...
openaire   +2 more sources

Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2009
We examined the efficacy and tolerability of perospirone, a dopamine D2 and 5-HT2A receptor antagonist and a partial 5-HT1A receptor agonist, in the augmentation of antidepressant treatment of partially responding and nonresponding patients with major depressive disorder.
Yasushi, Sato   +4 more
openaire   +2 more sources

The combination of duloxetine and bupropion for treatment-resistant major depressive disorder

Depression and Anxiety, 2006
Our objective was to assess the effectiveness and safety of the combination of duloxetine and bupropion for treatment-resistant major depressive disorder (TRD). A retrospective chart review was conducted to identify patients with major depressive disorder (MDD) who had not experienced full remission of symptoms following an adequate trial of either ...
George I, Papakostas   +8 more
openaire   +2 more sources

Mismatch negativity in treatment-resistant depression and borderline personality disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2010
Cognitive dysfunctions, such as attentional impairment, are central features of both treatment-resistant depression (TRD) and borderline personality disorder (BPD). The treatment failure of TRD due to its comorbidity with BPD is debated in the literature.
Wei, He   +7 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy